Vanguard Fiduciary Trust
FTH

Vanguard Fiduciary Trust’s Faeth Therapeutics FTH Stock Holding History

Vanguard Fiduciary Trust’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Hold
6,307
– – ﹤0.01% 3643
2026
Q1 		$199K Buy
+6,307
New +$126K ﹤0.01% 3524

Other funds holding FTH

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Vanguard Fiduciary Trust's FTH Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Faeth Therapeutics (FTH) position steady in Q2 2026 at 6,307 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #3643.

Vanguard Fiduciary Trust first reported a position in FTH in Q1 2026 and has held it in 2 quarters since. The position peaked at $199K in Q1 2026. 45 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

  • Vanguard Fiduciary Trust held 6,307 shares of Faeth Therapeutics worth $158K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Faeth Therapeutics share count unchanged in Q2 2026.
  • Faeth Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3643 holding.
  • Vanguard Fiduciary Trust first reported a position in Faeth Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Faeth Therapeutics position peaked at $199K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.